- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
S
SNOA
Sonoma Pharmaceu
2.94
0.10+3.52%After Hours: 2.820 -0.12 -4.08%17:40 02/20 EST
OPEN/PREV CLOSE2.840/2.840
TODAY RANGE2.840-2.975
VOL7.93K
MARKET CAP5.09M
52 WEEK RANGE1.750-6.92
AVG VOL (3M)20.02K
% TURNOVER0.46%
TURNOVER--
P/E (TTM)-1.4413
% RANGE5.46%
EPS(TTM)-2.0398
P/E(FORWARD)-1.8261
P/B1.483
BVPS1.983
DIVIDEND--
P/S0.3363
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.03M
SHARES OUTSTANDING1.73M
NEXT EARNINGS06/15-06/19
FREE FLOAT1.71M
LOT SIZE1
EX-DATE08/30/2024
News
Press Releases
Financial Reports
Profile
Seeking Alpha·02/10 21:44
Sonoma Pharmaceuticals GAAP EPS of -$0.48, revenue of $4.3M
Reuters·02/10 21:18
Sonoma Pharmaceuticals Q3 revenue rises 22%
Reuters·02/10 21:10
SONOMA PHARMACEUTICALS Q3 NET INCOME USD -600 THOUSAND
Reuters·02/10 21:02
Sonoma Pharma Europe revenue up 31% to USD X in Q3
TipRanks·01/12 14:11
Sonoma Pharmaceuticals Updates Investor Presentation on HOCl Portfolio
Reuters·01/02 22:19
Sonoma Pharmaceuticals Grants Equity Awards to Executives and Directors
TipRanks·11/13/2025 13:50
Sonoma Pharmaceuticals’ Reliefacyn Advanced receives NRS Seal of Acceptance
Reuters·11/06/2025 21:01
Sonoma Pharmaceuticals to Exhibit at MEDICA in Düsseldorf
Seeking Alpha·11/04/2025 17:16
Sonoma Pharmaceuticals GAAP EPS of -$0.32 misses by $0.01, revenue of $5.6M beats by $1.34M
Reuters·11/04/2025 14:04
Sonoma Pharmaceuticals Q2 revenue beats expectations on increased distributor sales
TipRanks·11/04/2025 14:00
Sonoma Pharmaceuticals reports Q2 EPS (32c) vs. (59c) last year
Same Industry
Name/Symbol
Change%
Price